The circumstances associated with high lithium concentrations detected by 23 district laboratories in the West Midlands during a 22 month period were investigated.
The effects of drugs are studied In the laboratory, In cllnclal trials and In day to day use. The latter has come to be regarded as clinical audit.
Many publications attest to the beneficial and toxic effects of lithium, and to the narrow dose range between the two1.Although serum lithium concentration is the best monitor of lithium toxicity, it is only an indirect measure; in particular, in unsteady state conditions it will not be an accurate index of tissue toxicity, and high lithium levels may precede (Sellers et al 1982) or follow (Amdisen, 1980) intoxication. Furthermore, patients as well as their individual organs vary in susceptibility to the toxic effects of lithium.
There is therefore no threshold serum concen tration at which lithium can be said to be toxic. Nevertheless, it is convenient to regard concen trations of 1.5 mmol/1 or more as being in the toxic range, since such concentrations are poten tially fatal.
This investigation examined the circumstances associated with lithium values in the toxic range in the West Midlands Region during a 22 month period.
The study
The 23 participating laboratories sent a short questionnaire to any doctor who had requested a lithium estimate proving to have a value of 1.5 mmol/1 or more. The investigation spanned the period from January 1991 to October 1992. Where more than one estimate in the toxic range arose from the same episode of toxicity, the maximum value was taken as the index value.
1. Technically, a low therapeutic ratio, that is, the ratio of the median lethal dose to the median effective dose.
Findings
Fifty-two separate instances of toxic values were recorded in 48 patients, one patient experiencing four and another patient two separate episodes (Table 1 ).The patient with four separate episodes was deliberately maintained at lithium values of about 1.2 mmol/1, because only then, the re spondent reported, was there freedom from disabling and frequent relapse.
The mean age of the patients who attained toxic levels was 58 years (s.d.=16 years, range 18 to 84 years). Thirty-six were female, 12 male. In 47 instances the patient was established on lithium, in four treatment was being initiated, and in one treatment had ended, the overdose coming from the remaining supply. The mean of the toxic values was 2.0 mmol/1 (s.d.=0.80, range 1.5-5). The mean period elapsing between the toxic episodes and a previous lithium estimate was 6.7 weeks with an interquartile range of 2-8.8 weeks. In several patients, more than one reason for an episode of intoxication was given. The value in parentheses gives the number of instances of the quoted reason being associated with another cause. Thus, of the 9 instances of blood being sampled too soon after the last dose, three were associated with some other cause.
Of the 30 respondents who told patients how long they should wait after their last dose before venesection for estimation, 20 quoted Amdisen's (1987) recommendation of 12 hours and seven others periods ranging from seven to 15 hours. Three quoted not a fixed period but a range so wide as to vitiate the estimate.
Some instances of intoxication
One patient who took a deliberate overdose had a maximum lithium value of 9.5 mmol/1 and died, despite a reduction to 2.5 mmol/1 on dialysis, probably because of the slow clearance of lithium. A 67-year-old woman on lithium was admitted to a general hospital with dehydration and a urinary infection. Her blood urea was 36.4 mmol/1 (normal 2.3-8). Lithium was prescribed but she refused it -refusing medication In hospital can sometimes be good for your health.
Comment
How might lithium intoxication be avoided? Educat ing both patient and doctor is crucially important. Peet & Harvey (1981) advocate the use of videotapes to educate patients. As with electroconvulsive therapy, there is a strong case for devoting a special session to lithium in postgraduate psychiatric training. Letters to family doctors when treatment is initiated might contain a concise statement of the monitoring recommendations and a reminder of adverse Interactions and of the dangers of lithium during pregnancy.
The most difficult decision falls to the family doctor -whether, during Intercurrent illness, to continue lithium, possibly at a reduced dose, or to stop It. The risk of affective relapse has to be weighed against that of lithium intoxication. Mander & Loudon (1988) reported that 50% of a group of patients with a history of mania relapsed within two weeks of lithium being deliberately stopped. Margo & McMahon (1982) On these considerations, the general practi tioner might reasonably resolve to stop lithium during any but the most trivial intercurrent illness, until a lithium estimate has been done, and to expect a psychiatrist to contribute to further management.
References AMDISEN, A. (1980) Schou (1988) suggested that routine monitoring is not worth the cost or effort, a refreshing statement on a topic that needed simplification. The issue turns on whether patients, once stabilised, will remain so. Kehoe & Mander (1992) found that in 18 of 458 patients there was a gradual Increase in serum lithium concentration during the course of a year, sufficient to require dose reduction. Such patients were found to have an unexplained 18% lower creatinlne clearance rate than controls {Kehoe, 1994). This Is important because 95% of ingested lithium is excreted renally (Dyson et al, 1987) . Until more is known, It is reasonable to follow the current BNF(1995) recommendation of monitoring at 3-monthly Intervals or even 6-monthly in young and middle-aged patients who are reliable (Ferrier et al 1995) .
However, there is no disagreement that it is essential to estimate serum lithium at the start of treatment, during intercurrent illness, and If there is the slightest suspicion of Intoxication.
The study
The Biochemistry Laboratory of the Shropshire District Health Authority, one of the 23 district laboratories in the West Midlands Region, keeps a record of all lithium estimates, together with information culled from the request forms. The quality of monitoring was assessed from these data which covered the interval from 1st January 1991 to 31st October 1992. All estimates were Included In the study.
The time elapsing between two consecutive estimates is referred to as the 'Interval' of the second estimate.
The estimates were considered as four classes, the boundaries being derived from the BNF( 1995):
(a) 0-0.3 mmol/l: probably too low to be effective; (b) 0.4-1.0 mmol/l: the recommended thera peutic range; (c) 1.1-1.4 mmol/l: effective but high, and usually incurring unnecessarily severe side-effects; and (d) 1.5 and above, 'toxic'.
If any lithium value lay outside the BNF range (0.4-1.0 mmol/l), or if any Interval was six months or more, or less than one month, further information was sought from case notes and from family doctor records.
Findings

General
The mean value of the 2697 lithium estimates was 0.63 mmol/l; 213 (7.9%) fell below the BNF range, 64 (2.4%) fell in the range 1.1-1.4 mmol/l, and 14 (0.5%) were in the toxic range.
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